Eloxx Pharmaceuticals, Inc.
ELOX
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.78M | 4.33M | 4.90M | 19.21M | 24.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 249.00K | 458.00K | 672.00K | 93.00K | 391.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 605.00K | 593.00K | 827.00K | 829.00K | 726.00K |
| Total Current Assets | 5.63M | 5.38M | 6.40M | 20.13M | 25.67M |
|
|
|||||
| Total Current Assets | 5.63M | 5.38M | 6.40M | 20.13M | 25.67M |
| Net Property, Plant & Equipment | 413.00K | 611.00K | 797.00K | 994.00K | 1.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.04M | 5.99M | 7.20M | 21.12M | 26.88M |
|
|
|||||
| Total Accounts Payable | 3.13M | 3.12M | 2.43M | 3.02M | 1.60M |
| Total Accrued Expenses | 2.44M | 2.75M | 2.23M | 2.80M | 4.52M |
| Short-term Debt | 12.97M | 12.54M | 12.54M | 12.54M | 12.22M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.13M | 2.77M | 2.20M | 4.69M | 3.23M |
| Total Finance Division Other Current Liabilities | 1.79M | 75.00K | 58.00K | 45.00K | 116.00K |
| Total Other Current Liabilities | 1.79M | 75.00K | 58.00K | 45.00K | 116.00K |
| Total Current Liabilities | 23.47M | 21.25M | 19.46M | 23.09M | 21.68M |
|
|
|||||
| Total Current Liabilities | 23.47M | 21.25M | 19.46M | 23.09M | 21.68M |
| Long-Term Debt | 2.62M | 3.33M | 4.03M | 8.56M | 9.86M |
| Short-term Debt | 12.97M | 12.54M | 12.54M | 12.54M | 12.22M |
| Capital Leases | 3.00K | 4.00K | 6.00K | 135.00K | 318.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.09M | 24.59M | 23.49M | 31.78M | 31.86M |
|
|
|||||
| Common Stock & APIC | 268.50M | 266.40M | 264.33M | 263.73M | 265.28M |
| Retained Earnings | -288.55M | -284.96M | -280.62M | -274.39M | -268.07M |
| Treasury Stock & Other | -- | -41.00K | -- | -- | -2.19M |
| Total Common Equity | -20.05M | -18.60M | -16.29M | -10.66M | -4.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.05M | -18.60M | -16.29M | -10.66M | -4.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.05M | -18.60M | -16.29M | -10.66M | -4.98M |
|
|
|||||